share_log

Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More

Benzinga ·  Apr 25, 2023 04:00

LSD Trial Study Shows Potential For Major Depression

  • Psychedelics biopharma companyMind Medicine Inc.(NASDAQ:MNMD) recently shared positive topline data from an advanced clinical trial of LSDas a treatment of Major Depressive Disorder (MDD).
  • The double-blind Phase 2 study demonstrated "significant, rapid, durable and beneficial effects" on the mitigation of MDD symptoms.Read more HERE.

Canada's Large Scale Psilocybin Macrodose Trial

  • Canadian biopharma companyApex Labs Ltd.,has received Health Canada's approval for a comprehensive, "statistically powered" macro-and-multi dose advanced psilocybin trial on 160 patients.
  • The trial's primary indication (severe depression within PTSD) is...
Login or create a forever free account to read this news
Sign up/Log in
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment